August 14, 2025

Senseonics Holdings, Inc. (SENS) Stock Analysis: Exploring a 192.93% Upside Potential in the Medical Device Sector

In the competitive realm of healthcare, Senseonics Holdings, Inc. (SENS) emerges as a notable player with its innovative approach to diabetes management. As a commercial-stage medical technology company, Senseonics is..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: Exploring a 61.63% Potential Upside in the Biotech Sector

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) has recently caught the attention of investors with its potential for significant stock price appreciation in the biotechnology sector. With a current market capitalization of..

Entrada Therapeutics, Inc. (TRDA) Stock Analysis: Exploring a Biotech Gem with a 247% Upside Potential

Entrada Therapeutics, Inc. (NASDAQ: TRDA) stands out in the biotechnology sector as a clinical-stage company focused on developing innovative therapeutics for neuromuscular diseases. With its promising endosomal escape vehicle (EEV)..

NetClass Technology Inc (NTCL) Stock Analysis: Navigating Volatility with Emerging Opportunities in the EdTech Sector

NetClass Technology Inc (NTCL) is a player in the burgeoning field of educational technology, providing online educational platforms and related services across China and several other regions. With a market..

ZoomInfo Technologies Inc. (GTM) Stock Analysis: Navigating a 15.49% Potential Upside in a Competitive Software Landscape

ZoomInfo Technologies Inc. (NASDAQ: GTM) stands as a formidable player in the technology sector, specifically within the software application industry, with a market capitalization of $11.33 billion. Specializing in go-to-market..

ServiceTitan, Inc. (TTAN) Stock Analysis: 23.64% Potential Upside and Strong Buy Ratings Highlight Investment Appeal

ServiceTitan, Inc. (TTAN) is capturing investor attention with its robust growth prospects and a notable 23.64% potential upside based on current analyst ratings. Operating within the technology sector, ServiceTitan provides..

Health Catalyst, Inc. (HCAT) Stock Analysis: Analyzing a 65.63% Potential Upside in Health Information Services

Health Catalyst, Inc. (NASDAQ: HCAT) operates in the dynamic healthcare sector, specifically within the health information services industry. The company is headquartered in South Jordan, Utah, and focuses on providing..

SoundHound AI, Inc. (SOUN) Stock Analysis: Unpacking the 217% Revenue Growth Amid Market Challenges

SoundHound AI, Inc. (SOUN) has been making waves in the technology sector, specifically within the software application industry. With a market capitalization of $6.73 billion, this Santa Clara-based company is..

A2Z Cust2Mate Solutions Corp. (AZ) Investor Outlook: Exploring a 103.67% Potential Upside

A2Z Cust2Mate Solutions Corp. (AZ), a Canadian technology player in the software application industry, has caught the eye of investors with its innovative smart cart solutions aimed at revolutionizing the..

Agora, Inc. (API) Stock Analysis: Unpacking a Potential 59% Upside

Agora, Inc. (NASDAQ: API) presents an intriguing opportunity for investors navigating the dynamic landscape of the technology sector. Specializing in real-time engagement platforms, Agora’s stock is currently priced at $3.8,..

Abeona Therapeutics Inc. (ABEO): Analyst Consensus Highlights a 203.79% Upside Potential

Abeona Therapeutics Inc. (NASDAQ: ABEO), a clinical-stage biopharmaceutical company based in Cleveland, Ohio, is making waves in the biotechnology sector. With a market capitalization of $335.59 million, Abeona is focused..

Cytek Biosciences, Inc. (CTKB) Stock Analysis: Exploring a 22.9% Potential Upside in the Healthcare Sector

Cytek Biosciences, Inc. (NASDAQ: CTKB), a key player in the healthcare sector, specializes in the development of cutting-edge cell analysis tools that support breakthroughs in biomedical research and clinical applications...

Neuronetics, Inc. (STIM) Stock Analysis: A 67.96% Potential Upside in the Healthcare Sector

Neuronetics, Inc. (NASDAQ: STIM) is generating buzz among investors with its promising 67.96% potential upside, as the company continues to carve out its niche in the healthcare sector, specifically within..

Tvardi Therapeutics, Inc. (TVRD) Investor Outlook: Exploring a Promising 137.69% Upside

Tvardi Therapeutics, Inc. (TVRD) stands at the forefront of innovative healthcare solutions with its focus on developing novel, oral, small molecule therapies targeting the STAT3 pathway. This clinical-stage biopharmaceutical company,..

Phathom Pharmaceuticals, Inc. (PHAT) Stock Analysis: Exploring a 95.61% Potential Upside with Strong Buy Ratings

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT), a dynamic player in the biotechnology sector, is catching the eye of investors with its promising potential upside of 95.61%. With a market capitalization of..

Candel Therapeutics, Inc. (CADL) Stock Analysis: A Biotech Gem with 228% Potential Upside

Candel Therapeutics, Inc. (NASDAQ: CADL), a pioneering force in the biotechnology sector, is capturing investor attention with its innovative approach to cancer treatment. This clinical-stage biopharmaceutical company, headquartered in Needham,..

Immutep Limited (IMMP) Stock Analysis: A High-Risk, High-Reward Biotech Play with a 449% Potential Upside

Immutep Limited (NASDAQ: IMMP), a Sydney-based biotechnology company, is carving a niche in the healthcare sector with its innovative immunotherapy solutions targeting cancer and autoimmune diseases. With a current market..

Palvella Therapeutics, Inc. (PVLA) Stock Analysis: A Biotech Contender with 20% Upside Potential

Investors seeking opportunities in the biotechnology sector may find Palvella Therapeutics, Inc. (PVLA) a compelling prospect. This clinical-stage biopharmaceutical company, based in Wayne, Pennsylvania, is making waves with its innovative..

Absci Corporation (ABSI) Stock Analysis: A Biotech Innovator with 167% Upside Potential

Absci Corporation (NASDAQ: ABSI), a cutting-edge player in the biotechnology sector, is capturing investor attention with its innovative approach to drug creation. As a company that marries artificial intelligence with..

Nyxoah SA (NYXH) Investor Outlook: Exploring a 102% Potential Upside in Medical Tech

Investors with an eye on the healthcare sector may find Nyxoah SA (NASDAQ: NYXH) a compelling addition to their portfolios, especially given its recent trading dynamics and promising analyst outlook...

Search

Funds

August 14, 2025

Search

Funds

August 14, 2025

FTSE 100

Funds